Connect
← Return to Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
Discussion
Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
Neuroendocrine Tumors (NETs) | Last Active: Jul 25, 2023 | Replies (14)Comment receiving replies
Unfortunately there are no trials with my rare cancer. No data on treatment so everything is a trial of sorts. No money in rare stuff. I’m also using Lycopene, quercetin and Curcumin in a rational cycle relative to chemo. Hope to develop a protocol of sorts for treatment for this cancer as the limited data appears to indicate 4.8 months median period for dx to dead. My initial pathology was in January of this year with pet scan confirmation of stage 4 in April. FOLFOX started 5/9. Just received second round of Pembrolizumab plus 5-FU/Lv today. Dosing ivermectin at 0.4mg/kg days 1-3 each week. Any additional info would be appreciated eve is anecdotal. Cheers!
Replies to "Unfortunately there are no trials with my rare cancer. No data on treatment so everything is..."
Merck the maker of Keytruda and Moderna the maker of mRNA vaccines are in partnership. They are running trials now using a combination of Keytruda and targeted vaccines created for individual patients based upon their specific tumor. The results thus far are very encouraging. I hope the link below will take you to the article I have referenced. One thing more are your thoughts, which have real power that can greatly influence the results you are seeking. Do your best to keep any doubts at bay because a treatment that will work for you is just around the corner.
https://www.reuters.com/business/healthcare-pharmaceuticals/cancer-vaccines-poised-unlock-new-treatment-paradigm-with-merckmoderna-data-2023-06-05/
What rare cancer so you have? I didn't see that you mentioned it.
Connect
Is this protocol recommended and/or monitored by your oncologist?